France Ingestible Sensors Market Size, Share, and COVID-19 Impact Analysis, By Component (Sensors and Software), By Vertical (Sports and Medical), and France Ingestible Sensors Market Insights, Industry Trend, Forecasts to 2035.

France Ingestible Sensors Market Insights Forecasts to 2035

• The France Ingestible Sensors Market Size was estimated at USD 48.85 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 9.95% from 2025 To 2035
• The France Ingestible Sensors Market Size is Expected to Reach USD 138.62 Million By 2035

The France Ingestible Sensors Market Size is Anticipated to reach USD 138.62 Million By 2035, Growing at a CAGR of 9.95% from 2025 To 2035. The growing demand for remote patient monitoring and advancements in smart healthcare technologies are driving France's ingestible sensors market.

Market Overview

The France ingestible sensors market is an emerging segment within the country's advanced healthcare technology sector. Ingestible sensors are tiny, biocompatible electronic devices that can be swallowed to monitor internal bodily functions such as temperature, pH, and pressure, particularly within the gastrointestinal tract. These sensors transmit data wirelessly to external devices, enabling real-time insights into a patient's internal health without the need for invasive procedures. In France, the market is primarily focused on medical diagnostics, chronic disease management, and monitoring medication adherence. Hospitals, research institutions, and medical technology companies are increasingly exploring the use of ingestible sensors as part of integrated digital health systems. The market features contributions from both domestic firms and international players, with applications extending across various medical disciplines. While still in a developmental phase compared to more established medical technologies, ingestible sensors are gaining attention for their potential to improve clinical outcomes and patient experience in the French healthcare environment.

Report Coverage

This research report categorizes the market for the France ingestible sensors market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France ingestible sensors market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France ingestible sensors market.

Driving Factors

Rising demand for minimally invasive diagnostic tools has increased interest in technologies that provide internal body data without surgery. The growing prevalence of gastrointestinal disorders, chronic illnesses, and aging populations further fuels the need for real-time health monitoring. Technological advancements in microelectronics and wireless communication enhance the reliability and functionality of ingestible sensors. Additionally, the increasing integration of digital health platforms in France supports the adoption of connected medical devices. Supportive government healthcare policies and investments in medical innovation also contribute to the expanding application of ingestible sensors across clinical settings.

Restraining Factors

Concerns over data privacy and security in transmitting sensitive health information further hinder acceptance. Additionally, limited awareness among healthcare professionals and patients, along with the need for specialized infrastructure to interpret and manage sensor data, restricts the integration of ingestible sensors into routine medical practice.

Market Segmentation

The France ingestible sensors market share is classified into component and vertical.

• The sensors segment held a leading revenue share in 2024 and is expected to grow at a substantial CAGR during the forecast period.

The France ingestible sensors market is segmented by component into sensors and software. Among these, the sensors segment held a leading revenue share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The dominance is attributed to the critical role sensors play as the core hardware responsible for capturing internal physiological data such as pH levels, temperature, and pressure. These sensors are engineered to function reliably within the human gastrointestinal tract, transmitting data to external systems for analysis.

• The medical segment held a significant market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The France ingestible sensors market is segmented by vertical into sports and medical. Among these, the medical segment held a significant market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The dominance is primarily due to the widespread use of ingestible sensors in clinical diagnostics, chronic disease management, and patient monitoring. In medical settings, these sensors offer non-invasive and real-time data collection from within the gastrointestinal tract, enabling more accurate diagnosis and treatment planning.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France ingestible sensors market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• BioSerenity
• Soitec S.A.
• Digital (Group Digital)
• Otsuka Pharmaceutical France
• Others

Recent Developments:

• In October 2023, French medtech company BodyCAP received U.S. FDA approval for its connected ingestible thermometer, the eCelsius Medical System. This device monitors core body temperature in real-time, aiding in the management of conditions like hyperthermia and hypothermia.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at France, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France ingestible sensors market based on the below-mentioned segments

France Ingestible Sensors Market, By Component

• Sensors
• Software

France Ingestible Sensors Market, By Vertical

• Sports

Medical